Speciality Medicines Ltd Board Approves FY26 Directors' Report, Calls AGM

Speciality Medicines Ltd announced the outcome of its board meeting held on September 03, 2026. The board approved the draft Directors' Report for the financial year 2025-26 and its annexures for inclusion in the Annual Report. Additionally, the company decided to convene its 5th Annual General Meeting (AGM) on September 28, 2026, to be held via Video Conferencing/Other Audio-Visual Means. NSDL has been appointed as the Remote E-Voting Agency, and CS Hardikkumar Jetani will serve as the Scrutinizer for the AGM's voting process. The Register of Members and Share Transfer Books will remain open.